BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

FORUM Pharmaceuticals (Formerly Known As EnVivo Pharmaceuticals, Inc.) 

480 Arsenal Street
Building 1
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-225-4250 Fax: 617-225-4267


SEARCH JOBS



Segment
Drug Discovery





 Company News
EnVivo Pharmaceuticals, Inc. Becomes FORUM Pharmaceuticals 4/2/2014 8:46:12 AM    More...
EnVivo Pharmaceuticals, Inc. Initiates COGNITIV AD, A Phase 3 Clinical Trial Program Of Encenicline (EVP-6124) In Alzheimer’s Disease 1/22/2014 9:24:17 AM    More...
Ex-Millennium: The Takeda Oncology Company CEO to Head EnVivo Pharmaceuticals, Inc. 7/11/2013 7:15:42 AM    More...
EnVivo Pharmaceuticals, Inc. Announces Initiation of Phase 2 Clinical Trial Program of EVP-0962 in Alzheimer’s Disease 1/3/2013 9:54:46 AM    More...
EnVivo Pharmaceuticals, Inc. Presents Additional EVP-6124 Phase 2b Clinical Trial Results at the Clinical Trials on Alzheimer’s Disease (CTAD) Meeting 10/31/2012 7:51:10 AM    More...
EnVivo Pharmaceuticals, Inc.' Drug Helps Memory in Early Study 7/18/2012 10:20:41 AM    More...
EnVivo Pharmaceuticals, Inc. to Present Phase 2b Clinical Data of Lead Program in Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2012 6/13/2012 10:38:51 AM    More...
EnVivo Pharmaceuticals, Inc. Names Christopher L. Burnley Chief Business Officer 4/19/2012 10:06:00 AM    More...
EnVivo Pharmaceuticals, Inc. Announces Neuropharmacology Publication, Confirms Novel Mechanism of Action of Lead Program EVP-6124 12/13/2011 7:16:19 AM    More...
EnVivo Pharmaceuticals, Inc. Posts Positive Phase 2b Study Results of Schizophrenia Drug 12/5/2011 6:55:33 AM    More...
1234

//-->